About Neal Koller
Form D filings for Alphyn Biologics from 2020 to 2024 list Neal Koller as chief executive officer and director.
Neal Koller first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Neal Koller in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Neal Koller works with at each company, as listed on that company's latest Form D.
Alphyn Biologics, Inc. · Form D, May 20, 2024
SP
Steven Pentelnik
Executive officer
JK
Jeffrey Kossak
Director
GP
Gary Pekoe
Executive officer and director
AM
Adel Mikhail
Director
RG
Roger Griggs
Director